Search
for
Sort by
Research 511–540 of 1000+
- Pertinence d’une chimioprévention à partir de l’étude PCPT
- PSA Test Sensitized by Finasteride
- Editorial comment
- Focus sulla finasteride: efficacia, meccanismi e raccomandazioni per l'uso clinico
- Reply by Authors
- Επικύρωση της χρησιμότητας των νεότερων παραμέτρων του PSA ορού για την ανίχνευση του καρκίνου του προστάτη
- Editorial Comment
- Editorial comment
- The Role of 5αR Inhibitors in the Early Growth of Pca Cells
- Enhancement of Intermittent Androgen Ablation Therapy by Finasteride Administration in Animal Models
- ダブルストロボレンジファインダの開発(特別講演)(画像センシングおよび一般)
- Combined C3b and Factor B Autoantibodies and MPGN Type II
- Health Issues Unique to the Aging Man
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Финастерид в профилактике прогрессирования рака предстательной железы
- 17-Oximino-5-androsten-3β-yl esters: synthesis, antiproliferative activity, acute toxicity, and effect on serum androgen level
- Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839
- This Month in Adult Urology
- Major role for 5-alpha reductase inhibitors in the aging male
- Erratum
- Regulation of masculinization: androgen signalling for external genitalia development
- Therapeutic Strategies to Target the Androgen Receptor
- Proscar and Propecia—A Therapeutic Perspective
- Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists
- The clinical applications of five-alpha reductase inhibitors.
- Structure of human type II 5 alpha-reductase gene
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- Genetic Analysis of Androgen Receptors in Development and Disease
- Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro